Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.10
Bid: 18.10
Ask: 18.60
Change: -0.35 (-1.90%)
Spread: 0.50 (2.762%)
Open: 18.10
High: 18.10
Low: 18.10
Prev. Close: 18.45
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter 2022 Update

27 Apr 2022 07:00

RNS Number : 4473J
LMS Capital PLC
27 April 2022
 

 

 

 

 

 

 

27 April 2022

 

 

LMS CAPITAL PLC

First Quarter 2022 Update

 

 

LMS Capital plc (the "Company"), a listed Investment Company, provides the following update covering the three months ended 31 March 2022.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2022 was £50.3 million (62.3p per share). This compares to £49.1 million (60.8p per share) at 31 December 2021;

· Unrealised portfolio gains of £1.3 million, including foreign exchange gains, and accrued interest income of £0.3 million from the Dacian Petroleum investment; and

· Cash at 31 March 2022 was £19.5 million compared to £20.1 million at 31 December 2021.

 

Unaudited Net Asset Value at 31 March 2022

 

The £1.2 million increase in NAV during the first quarter is comprised of the following:

· Unrealised gains of £0.6 million on the mature investment portfolio;

· Accrued interest income of £0.3 million on the Dacian Petroleum investment;

· £0.7 million of portfolio and £0.1 million of non-portfolio foreign exchange gains from the strengthening of the U.S. Dollar against sterling; and

· £0.4 million of running costs and £0.1 million of investment related costs.

 

 

 

 

The 31 March 2022 NAV is summarised below:

 

 

Unaudited

Audited

 

31 March

2022

31 December

 2021

 

£ 000s

Mature Investment Portfolio

 

 

Quoted Investments

297

383

Unquoted Investments

9,078

8,668

Funds

14,755

13,929

 

24,130

22,980

New Investment Portfolio

 

 

Quoted Investments

-

-

Unquoted Investments

8,470

7,958

Funds

-

-

 

8,470

7,958

 

 

 

Total Investments

32,600

30,938

Cash

19,458

20,113

Other Net Assets/Liabilities 

(1,746)

(1,942)

Net Asset Value

50,312

49,109

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2021, adjusted for transactions in the three months ended 31 March 2022, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

Portfolio Unrealised Net Gains

 

The portfolio net unrealised gains of £0.6 million and £0.3 million of accrued interest income, excluding foreign exchange movements, are summarised below:

 

Quoted Investments

 

The Company's quoted investment valuations decreased by a net £0.1 million during the first quarter of 2022, reflecting underlying market price decreases.

 

Unquoted Investments

 

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost and Elateral, assets managed by San Francisco Equity Partners (ICU Eyewear and YesTo), and a convertible debt instrument with IDE Group Holdings.

 

Total unquoted investment unrealised gains were nil during the first quarter as a £0.1 million gain in Medhost was offset by a £0.1 million loss in Elateral.

 

Dacian Petroleum had £0.3 million in investment accrued interest income during the first quarter.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net gains were £0.7 million. The principal movements were:

· Opus Capital Venture Partners - Unrealised gain of £1.1 million, driven by a significant uplift in the fund manager's valuation of one of the Fund's two principal remaining investments;

· Brockton Capital Fund 1 - Unrealised gain of £0.4 million, reflecting the unwinding of the discount rate as the investment is valued on a discounted cash flow basis;

· Eden - Unrealised loss of £0.4 million;

· Weber Capital Partners - unrealised loss of £0.3 million due to the performance in the U.S. microcap equities held in the fund; and

· Other unrealised losses on funds of £0.1 million.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2021 fund valuation reports except for Weber Capital Partners, which is based on 31 March 2022 valuations.

 

Portfolio Realisations

 

There were fund distributions of £0.1 million during the first quarter.

 

Liquidity and Outlook

 

The Company continues to maintain significant cash balances, £19.5 million at 31 March 2022. The Board is reviewing a number of opportunities with its real estate team, as well as further investment opportunities, but continues to take a cautious stance in the way the company's resources are deployed.

 

 

 

 

 

For further information please contact:

LMS Capital PLC

Nick Friedlos, Managing Director

0207 935 3555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFIFMLTMTTTBTT
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.